Researchers say this breakthrough could lead to more effective prevention strategies and future therapies. Study: The plasma miRNAome in ADNI: Signatures to aid the detection of at-risk individuals.
Daratumumab-lenalidomide maintenance significantly increases MRD-negative conversion and reduces progression risk in multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results